跳至主要内容
临床试验/NCT00409526
NCT00409526终止4 期

Pilot Study: The Effect of Inhaled Iloprost on Oxygenation in Term and Near Term Infants With Pulmonary Hypertension. Testing Two Doses.

University of Chicago2 个研究点 分布在 2 个国家目标入组 1 人开始时间: 2006年12月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
1
试验地点
2
主要终点
Oxygenation index and PaO2 after treatment with inhaled Iloprost.

研究概览

简要总结

Inhaled Iloprost will be administered to near term infants with Persistent Pulmonary Hypertension of the Newborn in two different doses in order to test safety and efficacy in reducing pulmonary artery pressure.

详细描述

Infants eligible for the study will be divided into two arms according to oxygenation index: Infants in arm A (OI <20) will receive nebulized Iloprost in a lower dose (50 ng/kg/min) for one hour, and a higher dose (100 ng/kg/min) for another hour. Infants in arm B (OI>20) will receive NO, and in addition will receive nebulized Iloprost in a lower dose for one hour and a higher dose for another hour.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 7 Days(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Near-term infants (>34 gestational age) with evidence of persistent pulmonary hypertension and severe hypoxia(PaO2<100 mmHg with mechanical ventilation with FiO2=100%).

排除标准

  • •Major congenital malformation
  • •Congenital diaphragmatic hernia
  • •Structural cardiac anomalies
  • •Hydrops fetalis
  • •Pulmonary hemorrhage
  • •Severe perinatal depression
  • •Patients on high frequency oscillation ventilator

结局指标

主要结局

Oxygenation index and PaO2 after treatment with inhaled Iloprost.

时间窗: three hours

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验